title: Treatment of thyroid cancer with the new oral agents.
authors.forename: J C
authors.initials: JC
authors.lastname: Galofré
authors.forename: J M
authors.initials: JM
authors.lastname: Gómez-Sáez
authors.forename: C A
authors.initials: CA
authors.lastname: Escola
authors.forename: E
authors.initials: E
authors.lastname: Anda
authors.forename: A
authors.initials: A
authors.lastname: Calleja
authors.forename: S
authors.initials: S
authors.lastname: Donnay
authors.forename: A
authors.initials: A
authors.lastname: Lucas-Martin
authors.forename: E
authors.initials: E
authors.lastname: Menéndez-Torre
authors.forename: V
authors.initials: V
authors.lastname: Pereg
authors.forename: B
authors.initials: B
authors.lastname: Pérez-Corral
authors.forename: J
authors.initials: J
authors.lastname: Santamaría
authors.forename: G
authors.initials: G
authors.lastname: Riesco-Eizaguirre
authors.forename: C
authors.initials: C
authors.lastname: Zafon
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006287:Health Planning Guidelines; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D012955:Societies, Medical
chemical_list: D000970:Antineoplastic Agents